Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 16, 2024 16:30 ET
CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024
CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with cardiovascular...
Apr 16, 2024 16:30 ET
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 7, 2024. A copy of the release will be available on...
Apr 16, 2024 16:30 ET
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Compensation Committee of the Company’s Board of Directors approved the...
Apr 16, 2024 16:30 ET
Mercer International Inc. Announces Conference Call for First Quarter 2024 Results
Mercer International (NASDAQ: MERC) will release its first quarter results for the period ending March 31, 2024 on Thursday, May 9, 2024, after the close of the market. Juan Carlos Bueno, President and Chief Executive Officer and Richard Short,...
Apr 16, 2024 16:30 ET
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
via IBN -- PaxMedica, Inc. (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced it has received an urgent request from the Ministry of Health (MOH) of Malawi, asking for emergency...
Apr 16, 2024 16:30 ET
Powell Industries Announces Date and Conference Call for Fiscal 2024 Second Quarter Results
Powell Industries, Inc. (NASDAQ: POWL), a leading supplier of custom engineered solutions for the management, control and distribution of electrical energy, today announced that it will release results for the fiscal second quarter ended March 31,...
Apr 16, 2024 16:30 ET
Weatherford Releases 2023 Digital Annual Update
Weatherford International plc (NASDAQ: WFRD) ("Weatherford" or the "Company") announced the release of its 2023 Annual Update, highlighting outstanding results for the year. The digital update showcases new technology developments, recent strategic...
Apr 16, 2024 16:25 ET
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced that it has...
Apr 16, 2024 16:23 ET
Sezzle to Participate in Upcoming Investor Conferences
Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, today announced that the Company’s management team will participate in the following investor conferences:  May 16, 2024: Sezzle will...
Apr 16, 2024 16:20 ET
Twin Disc Announces Details of Fiscal 2024 Third Quarter Earnings Release, Webcast, and Conference Call
Twin Disc, Inc. (NASDAQ: TWIN), today announced that it will release its fiscal 2024 third-quarter results at approximately 8:00 am Eastern on April 30, 2024, and host a webcast and conference call to discuss those results at 9:00 am Eastern....
Apr 16, 2024 16:17 ET
Enterprise Bancorp, Inc. Announces Quarterly Dividend
Enterprise Bancorp, Inc. (the "Company") (NASDAQ:EBTC) On April 16, 2024, the Board of Directors of Enterprise Bancorp, Inc. declared a quarterly dividend of $0.24 per share to be paid on June 3, 2024, to shareholders of record as of May 13, 2024....
Apr 16, 2024 16:15 ET
AMD to Report Fiscal First Quarter 2024 Financial Results
AMD (NASDAQ: AMD) announced today that it will report fiscal first quarter 2024 financial results on Tuesday, Apr. 30, 2024, after the close of market. Management will conduct a conference call to discuss these results at 5:00 p.m. EDT / 2:00 p.m....
Apr 16, 2024 16:15 ET
K92 Mining 2024 First Quarter Financial Results Conference Call Details
K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) announces that it will release its 2024 first quarter financial results before the North American trading markets open on Monday, May 13, 2024. Conference Call and Webcast to...
Apr 16, 2024 16:15 ET
Mercury Systems to Report Third Quarter Fiscal Year 2024 Financial Results on May 7, 2024
Mercury Systems Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing power to the edge, will release its third quarter fiscal year 2024 financial results after the market close on Tuesday, May 7, 2024....
Apr 16, 2024 16:12 ET
NetLogistik Partners With Vuzix Wholly Owned Subsidiary Moviynt to Offer Mobility Solutions for the Warehouse
NetLogistik, the leader in powerful services that guide companies toward the digital transformation of the supply chain, announces a referral partnership with Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of...
Apr 16, 2024 16:11 ET
Oil-Dri to Acquire Ultra Pet in Strategic Move to Compete in Rapidly Growing Crystal Cat Litter Market
Oil-Dri Corporation of America (NYSE: ODC) (“Oil-Dri”), a leading manufacturer of sorbent minerals including clay-based cat litter, announced today that it has entered into a definitive agreement to acquire privately-held Ultra Pet Company, Inc....
Apr 16, 2024 16:10 ET
SiriusPoint Announces Date for First Quarter 2024 Earnings Release
SiriusPoint Ltd. (NYSE: SPNT) (“SiriusPoint” or the “Company”) today announced that it is planning to release its first quarter 2024 financial results after the market close on Tuesday, April 30, 2024. The Company will also hold a webcast, which...
Apr 16, 2024 16:10 ET
Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Conference Call on May 8th
After the close of market trading on Tuesday, May 7, 2024, Angi Inc. (NASDAQ: ANGI) will post its first quarter results at ir.angi.com/quarterly-earnings. On Wednesday May 8, 2024, at 8:30 a.m. ET, Angi Inc. and IAC will host a conference call to...
Apr 16, 2024 16:10 ET
Rumble Announces Timing of First Quarter 2024 Earnings Release and Conference Call
Rumble Inc. (NASDAQ: RUM) (“Rumble” or the “Company”), the video platform and cloud services provider, today announced that it will release financial results for the fiscal quarter ended March 31, 2024 after the close of markets on Tuesday, May 14,...
Apr 16, 2024 16:06 ET
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it has...